Skip to main content
OpenTrials
Completed

NCT Number: NCT05569850

Efficacy of an Antibacterial Toothpaste and Patients' Satisfaction

The primary objective of this randomized controlled clinical trial (RCCT) will be to compare the efficacy in reducing the quantity of Streptococcus mutans (S. Mutans) in saliva of a recently introduced toothpaste compared to a commercially available toothpaste. The secondary outcomes will be to assess patients' impression of the toothpastes (in terms of taste, satisfaction etc.), and to investigate potential changes in dentin hypersensitivity, plaque formation and gingival inflammation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

DIBINEM

Bologna, BO, 40125, Italy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with minimum 20 teeth;
  • Good oral hygiene level (gingival bleeding index not exceeding 20%)
  • Patients willing to participate in the study and able to sign an informed consent

Exclusion criteria

  • Tooth anomalies (amelogenesis imperfecta, dentinogenesis imperfecta etc.);
  • Intrinsic stain (fluorosis);
  • Caries lesions;
  • Advanced periodontal disease (probing >2, spontaneous gum bleeding, tooth mobility >1);
  • Smokers;
  • Use of orthodontic devices;
  • Use of antibiotics in the last 3 months;
  • Use of antibacterial mouth rinses in the last 3 months;
  • Potential allergies;
  • Drug and alcohol abuse;

Treatment and study plan

Brushing

Other

Brushing the teeth 2x a day for 4 weeks.

Primary outcomes

  1. Bacterial Count of Streptococcus Mutans (S. Mutans)

    Time frame: 4 weeks

    Agar Mitis salivarius with tellurium and bacitracin (MSTB) will be used for S. mutans isolation. The 0.1 ml saliva sample will be diluted with 0.9 ml of sterile normal saline; next, decimal dilutions of saliva will be made up to 10-3. Each medium plate will be cultured from 0.1 ml of the previously diluted sample to 10-3; then, the sample will be uniformly spread on the agar plates. Finally, the plates will be sealed. They will be incubated for 48 hours at 37°C. The bacterial colonies will be observed under a stereo microscope and identified by morphology and color. The CFU will be multiplied by the number of times the sample was originally diluted and expressed as the number of colony forming units per millilitre (CFU/mL) of saliva.

Secondary outcomes

  1. Plaque Index

    Time frame: 4 weeks

    The plaque will be disclosed using a disclosing solution and recorded as follows: score 0 = absence of plaque; score 1 = separate flecks of plaque on the cervical margin; score 2 = a thin, continuous band of plaque [up to 1 mm] at the cervical margin of the tooth; score 3 = a band of plaque wider than 1 mm, but covering less than one-third of the tooth crown; score 4 = plaque covering at least one-third, but less than two-third of the crown of the tooth; score 5 = plaque covering 2/3-crown or more of the crown of the tooth.

  2. Gingival Index

    Time frame: 4 weeks

    A North Carolina periodontal probe (Hu-Friedy, Chicago, IL, USA) will be used for determine gingival index according to the following scale: score 0 = absence of inflammation; score 1 = mild inflammation-slightly slight change in color and little change in texture; score 2 = moderate inflammation-moderate glazing, redness, edema, and hypertrophy; score 3 = severe inflammation-marked redness and hypertrophy.

  3. Dentin Hypersensitivity

    Time frame: 4 weeks

    Patients with self-reported dentin hypersensitivity will be considered. A 1-s air blast from approximately 1 cm distance will be applied onto exposed dentine. The participant's response will be assessed using the 4-point Schiff Sensitivity Scale (from 0: participant does not respond, to 3: participant responds to stimulus, considers it painful, and requests discontinuation;

  4. Tooth Colour

    Time frame: 4 weeks

    Participants' satisfaction before and after treatment will be recorded and the difference will be assessed. In order to obtain the data concerning patients' satisfaction with tooth color, a questionnaire containing aesthetic numeric visual-analogue scale ranging from 1 to 10 will be given to the subjects.

    1 = "Not satisfied at all" and 10 = "Very satisfied"

Sponsors and collaborators

Lead sponsor

University of Bologna

Other

Collaborators

  • Unilever R&D

Registry information

Official study title

In Vivo Evaluation of Antibacterial Toothpaste Efficiency and Patients' Satisfaction: a Double-blind Randomised Controlled Trial

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Oct 6, 2022
Registry last updated
Apr 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.